Plasmid delivery in vivo from porous tissue-engineering scaffolds

Transgene expression and cellular transfection

Jae-Hyung Jang, Christopher B. Rives, Lonnie D. Shea

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.

Original languageEnglish
Pages (from-to)475-483
Number of pages9
JournalMolecular Therapy
Volume12
Issue number3
DOIs
Publication statusPublished - 2005 Sep 1

Fingerprint

Tissue Scaffolds
Tissue Engineering
Transgenes
Transfection
Plasmids
Polyglactin 910
Specific Gravity
Vascular Endothelial Growth Factor A
Genes
Blood Vessels
Polymers
Gases
Maintenance

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

@article{b345fea720ee4df399fa098cd67dcbd8,
title = "Plasmid delivery in vivo from porous tissue-engineering scaffolds: Transgene expression and cellular transfection",
abstract = "Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.",
author = "Jae-Hyung Jang and Rives, {Christopher B.} and Shea, {Lonnie D.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.ymthe.2005.03.036",
language = "English",
volume = "12",
pages = "475--483",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "3",

}

Plasmid delivery in vivo from porous tissue-engineering scaffolds : Transgene expression and cellular transfection. / Jang, Jae-Hyung; Rives, Christopher B.; Shea, Lonnie D.

In: Molecular Therapy, Vol. 12, No. 3, 01.09.2005, p. 475-483.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasmid delivery in vivo from porous tissue-engineering scaffolds

T2 - Transgene expression and cellular transfection

AU - Jang, Jae-Hyung

AU - Rives, Christopher B.

AU - Shea, Lonnie D.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.

AB - Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.

UR - http://www.scopus.com/inward/record.url?scp=23844480941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844480941&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2005.03.036

DO - 10.1016/j.ymthe.2005.03.036

M3 - Article

VL - 12

SP - 475

EP - 483

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 3

ER -